Uncategorized

istock 489268017

Sunscreen Is Protective Against Skin DNA Damage

Summary: TAKE-HOME MESSAGE The authors of this systematic review evaluated the effectiveness of sunscreen use in humans for the prevention of DNA damage in vivo when applied prior to ultraviolet radiation (UVR) exposure. In all 10 studies included, significantly reduced levels of UVR-induced DNA damage were found in sunscreen-protected skin. There is consistent evidence that …

Sunscreen Is Protective Against Skin DNA Damage Read More »

Mole SkinCancer

Mohs an Option in Older Patients with Non-Melanoma Skin Ca

Summary: Good 8-year survival outcomes seen in patients 85 and up by Ed Susman  –  Contributing Writer, MedPage Today March 07, 2017 Action Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. ORLANDO …

Mohs an Option in Older Patients with Non-Melanoma Skin Ca Read More »

harrisunbrella

Beach Umbrella Provides Less Sun Protection Than Sunscreen With a High SPF

Summary: TAKE-HOME MESSAGE A cohort of 81 study participants were randomized to sun protection using a beach umbrella or sunscreen with a sun protection factor of 100 on a sunny beach for 3 hours at midday. The umbrella group showed a significant increase in sunburn scores for all body sites compared with baseline. In addition, …

Beach Umbrella Provides Less Sun Protection Than Sunscreen With a High SPF Read More »

istock 92967753

FDA Approves Second Targeted Combination Therapy For Advanced Melanoma

Summary: The US Food and Drug Administration (FDA) approved the combination targeted therapy vemurafenib-cobimetinib (Zelboraf-Cotellic) for about half of all patients with Stage IV melanoma that is inoperable or has metastasized throughout the body. On November 10, the US Food and Drug Administration (FDA) approved the combination targeted therapy vemurafenib-cobimetinib (Zelboraf-Cotellic) for about half of all patients …

FDA Approves Second Targeted Combination Therapy For Advanced Melanoma Read More »

JOIN OUR NEWSLETTER

Scroll to Top